Antares Pharma (AIS)
Antares Pharma Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 71.00% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -1.08% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 4.440 |
| Debt to Equity Ratio | 0.00 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -9.97% |
| Year to Date Stock Returns | 31.36% |
| 1 Year Stock Returns | 58.79% |
| 3 Year Stock Returns | 489.8% |
| 52 Week High | 3.44 |
| 52 Week Low | 1.51 |
Income Statement
| Revenues TTM | 19.75M |
| Revenue Per Share TTM | 0.1905 |
| Revenue Growth | 92.31% |
| Gross Profit TTM | 12.42M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -3.082M |
| Earnings Per Share TTM | |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -15.70M |
| Cash Financing TTM | 22.54M |
| Cash Operations TTM | -1.735M |
| Capital Expenditures | 0.2053M |
Share Statistics
| Shares Outstanding | 103.70M |
Balance Sheet
| Cash and ST Investments | 30.19M |
| Total Assets | 40.73M |
| Liabilities | 8.632M |
| Book Value | 32.09M |
| Book Value per Share | 0.3095 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these AIS related companies
AIS News
@ANDISIK try to get timing/Entry better next time $AIS.Over history its proven 2 bounce back,so buy big dips not tops,n you'll luv this name
about 2 hours ago by HighGrowthFinancial
about 2 hours ago by HighGrowthFinancial
@HighGrowthFinancial $AIS is not hard but impossible to predict the price movement. Kills me that I could be making $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS not buying this dip just yet, its been bouncing back from sub $3 everytime, not sure about this one though
about 3 days ago by HighGrowthFinancial
about 3 days ago by HighGrowthFinancial
@GPrime, $AIS, Example of making money elsewhere, bought SPPI yesterday at $10.76, its now at $11.20, a 4% gain.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS, really does test your patience. If it can't hold ~ $2.90, I'm going to start getting out. Buy back when lower or go make $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
RT @casualtrader: Long $AIS Long will run into next earning date $CLSN Celsion buy @ 1,6 ~ 1,8 run up come by end of this year 8$ come
about 4 days ago by BioInvestor
about 4 days ago by BioInvestor
@casualtrader, $AIS. You should check out $SPPI, great company. I actually got back in today. ·
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
@markf @ANDISIK any other biotech ideas? Long $AIS, looking to initiate long position $ZLCS. Thoughts?
about 4 days ago by casualtrader
about 4 days ago by casualtrader
@markf $AIS not that I'm aware of.Just a safer long term biotech investment with huge potential. Don't need to put all $ in riskier biotechs
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
On 5/19/12 Columbine Capital Services upgraded $AIS from Neutral to Favorable.
about 6 days ago by ANDISIK
about 6 days ago by ANDISIK
RT @markf: $AIS on Aug 8th..?? on earnings day for $AIS next earning is Aug 7 or 8 2012 positive earning come 100%
about 10 days ago by BioInvestor
about 10 days ago by BioInvestor
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing
May 15, 7:00AM Business Wire
May 15, 7:00AM Business Wire
Antares Pharma to Present at the 15th Annual Bank of America Merrill Lynch Health Care Conference
May 10, 7:00AM Business Wire
May 10, 7:00AM Business Wire
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
May 08, 7:00AM Business Wire
May 08, 7:00AM Business Wire
Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
Apr 26, 9:26AM Business Wire
Apr 26, 9:26AM Business Wire
Watson and Antares Announce the Introduction of Gelnique 3%™, for the Treatment of Overactive Bladder
Apr 26, 7:00AM PR Newswire
Apr 26, 7:00AM PR Newswire
Antares Pharma to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 7:00AM Business Wire
Mar 28, 7:00AM Business Wire
Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry
Mar 22, 8:20AM Marketwire
Mar 22, 8:20AM Marketwire
Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Mar 12, 7:00AM Business Wire
Mar 12, 7:00AM Business Wire
Antares Pharma Appoints John J. Howarth Vice President of Corporate Affairs
Feb 27, 9:30AM Business Wire
Feb 27, 9:30AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AIS | 2.89 | +0.02 | +0.70% | 299.69M |
| AIRT | 9.250 | +0.17 | +1.87% | 22.66M |
| AIRM | 91.97 | -0.12 | -0.13% | 1.159B |
| AIR | 12.48 | -0.29 | -2.27% | 502.69M |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AMS | 3.09 | +0.03 | +0.98% | 14.24M |
| AMRS | 2.57 | +0.20 | +8.44% | 144.59M |
| AMRI | 2.71 | -0.05 | -1.81% | 83.39M |
| AMRC | 11.07 | -0.15 | -1.34% | 289.15M |
| AMPL | 0.185 | +0.01 | +2.83% | 10.38M |
